JW55 JW55;N-(4-((4-(4-Methoxyphenyl)tetrahydro-2H-pyran-4-yl)MethylcarbaMoyl)phenyl)furan-2-carboxaMide;N-[4-[[[[Tetrahydro-4-(4-methoxyphenyl)-2H-pyran-4-yl]methyl]amino]carbonyl]phenyl]-2-furancarboxamid 664993-53-7
JW 55 is an inhibitor of the PARP domain of tankyrase 1 and 2 (TNKS1/2). JW55 decreased auto-PARsylation of TNKS1/2 in vitro with IC50 values of 1.9 uM and 830 nM respectively.
IC50 Value: 1.9 uM (TNKS1); 830 nM (TNKS2) [1]
Target: Tankyrase1/2; PARP
JW 55 efficacy causes stabilization of Axin2 and it increases degradation of β-catenin signaling pathway. JW 55 also decreases canonical Wnt signaling in SW480 and HCT-15 colon carcinoma cell lines. Wnt3a-induced HEK293 cells containing a transiently transfected ST-Luc (SuperTop-luciferase) reporter showed inhibition by JW55 with an IC50 value of 470 nM. In contrast, Shh Light II cells (Gli1-Luc reporter) that were activated with 50% Shh-CM were not inhibited by 10 or 1 μmol/L JW55. Also, TNFαactivated HEK293 cells containing a transiently transfected NF-κB-Luciferase (NF-κB-Luc) plasmid showed no pathway inhibition in the presence of 10 or 1 μmol/L of JW55 [1].
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View